Jag Capital Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
Jag Capital Management's AZN Position: Q4 2023 in Review
Jag Capital Management sold out of AstraZeneca (AZN) in Q4 2023, closing a stake of 14,602 shares — an estimated $1.98M sold.
Jag Capital Management first reported a position in AZN in Q2 2019 and held it in 18 quarters. The position peaked at $2.1M in Q2 2023. 1,130 funds tracked by Wall St. Rank hold AZN as of Q4 2023.
- Jag Capital Management reported no remaining AstraZeneca position as of Q4 2023 after selling out during the quarter.
- Jag Capital Management sold 14,602 AstraZeneca shares in Q4 2023, an estimated $1.98M.
- Jag Capital Management first reported a position in AstraZeneca in Q2 2019 and held it in 18 quarters.
- Jag Capital Management's AstraZeneca position peaked at $2.1M in Q2 2023.
- 1,130 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2023.
Based on Jag Capital Management's 13F filing for Q4 2023, filed 8 Feb 2024.